These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21948613)

  • 1. Concise review: The magic act of generating induced pluripotent stem cells: many rabbits in the hat.
    Mostoslavsky G
    Stem Cells; 2012 Jan; 30(1):28-32. PubMed ID: 21948613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: Oct4 and more: the reprogramming expressway.
    Sterneckert J; Höing S; Schöler HR
    Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of reprogramming efficiency between transduction of reprogramming factors, cell-cell fusion, and cytoplast fusion.
    Hasegawa K; Zhang P; Wei Z; Pomeroy JE; Lu W; Pera MF
    Stem Cells; 2010 Aug; 28(8):1338-48. PubMed ID: 20572011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer.
    Miller JD; Schlaeger TM
    Methods Mol Biol; 2011; 767():55-65. PubMed ID: 21822867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induced pluripotent stem cells generated from reprogramming differentiated cells by defined factors].
    Xia X; Chu J; Chen X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1121-7. PubMed ID: 18837383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming of somatic cells.
    Rajasingh J
    Prog Mol Biol Transl Sci; 2012; 111():51-82. PubMed ID: 22917226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different developmental potential of pluripotent stem cells generated by different reprogramming strategies.
    Jiang J; Ding G; Lin J; Zhang M; Shi L; Lv W; Yang H; Xiao H; Pei G; Li Y; Wu J; Li J
    J Mol Cell Biol; 2011 Jun; 3(3):197-9. PubMed ID: 21624975
    [No Abstract]   [Full Text] [Related]  

  • 11. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple and efficient method for generation of induced pluripotent stem cells using piggyBac transposition of doxycycline-inducible factors and an EOS reporter system.
    Tsukiyama T; Asano R; Kawaguchi T; Kim N; Yamada M; Minami N; Ohinata Y; Imai H
    Genes Cells; 2011 Jul; 16(7):815-25. PubMed ID: 21658168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.
    Desponts C; Ding S
    Methods Mol Biol; 2010; 636():207-18. PubMed ID: 20336525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary cell reprogramming systems: as years go by.
    Nagy A
    Curr Opin Genet Dev; 2013 Oct; 23(5):534-9. PubMed ID: 23968685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-mediated somatic cell reprogramming.
    Kuo CH; Ying SY
    J Cell Biochem; 2013 Feb; 114(2):275-81. PubMed ID: 22961769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSCs from cancer cells: challenges and opportunities.
    Ramos-Mejia V; Fraga MF; Menendez P
    Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell fate plug and play: direct reprogramming and induced pluripotency.
    Chambers SM; Studer L
    Cell; 2011 Jun; 145(6):827-30. PubMed ID: 21663788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
    Anastasia L; Pelissero G; Venerando B; Tettamanti G
    Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.